NCT06473701View on ClinicalTrials.gov

Reducing Breathlessness With Dronabinol in COPD Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
COPDBreathlessnessCannabis
Interventions
DRUG

Dronabinol 2.5mg Capsule

Dronabinol 2.5 mg pr capsule. Titration up till 20 mg daily dose.

DRUG

Placebo

Dronabinol-matched placebo capsule containing no active substance.

Trial Locations (1)

7100

RECRUITING

Vejle Hospital - A part of Lillebaelt Hospital, Vejle

All Listed Sponsors
collaborator

Region of Southern Denmark

OTHER

collaborator

Odense Patient Data Explorative Network

OTHER

collaborator

University of Southern Denmark

OTHER

collaborator

University of Aarhus

OTHER

lead

Vejle Hospital

OTHER